Availability of experimental treatments

50-12-103 . Availability of experimental treatments. (1) A manufacturer, health care provider, or health care facility may make an experimental treatment available upon a patient's request. (2) The manufacturer, health care provider, or health care facility may: (a) provide an experimental treatment to a patient without receiving compensation; or (b) establish payment arrangements with a patient for an experimental treatment. (3) A manufacturer, health care provider, or health care facility is not required to make an experimental treatment available to a patient.